Market Cap

Alzinova AB Market Capitalization:

kr139.8 Million

SEK as of Jan. 1, 2024

US$13.9 Million

business Alzinova AB Company Profile

Alzinova AB Main Stock Listing

OMX: ALZ

Market Capitalization History of Alzinova AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Alzinova AB market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr139.8 M 21.50%
Jan. 1, 2023 kr115.1 M -45.10%
Jan. 1, 2022 kr209.6 M -19.73%
Jan. 1, 2021 kr261.1 M -26.18%
Jan. 1, 2020 kr353.7 M -61.25%
Jan. 1, 2019 kr912.9 M 65.30%
Jan. 1, 2018 kr552.3 M 4.79%
Jan. 1, 2017 kr527.0 M 75.79%
Jan. 1, 2016 kr299.8 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Alzinova AB Categories

Sweden languages Healthcare languages Biotechnology
Sweden Healthcare Sweden Biotechnology

Stocks & Indices

Alzinova AB has the following listings and related stock indices.


Stock: OMX: ALZ

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.